All Stories

  1. The association of GSTT1 deletion, HindIII C>G PAI-1, and rs11808092 polymorphisms with Parkinson's Disease susceptibility: A genetic study in an Egyptian Cohort.
  2. Key genetic variants with multiple sclerosis risk in Egyptian patients
  3. Fecal Calprotectin and CRP: Noninvasive Biomarkers in IBD
  4. The Role of Plasma miR-124-3p and miR-574-3p Markers in Familial Mediterranean Fever Patients
  5. Molecular characterization of imprinting disorders: Beckwith–Wiedemann, Silver–Russell, and Prader-Willi syndromes in Egyptian patients
  6. Insight into Apert Syndrome: Reporting on Six Patients and Increasing Awareness
  7. Copy number variations: reliable diagnostic markers for Prader-Willi patients
  8. Molecular and Clinical Characterization of a Cohort of Autosomal Recessive Sensorineural Hearing Loss in Egyptian Patients
  9. Potential biomarkers of ASD a target for future treatments: oxidative stress, chemokines, apoptotic, and methylation capacity
  10. Correction: Emanuel syndrome due to unusual pattern
  11. Insight into the Blood Microbiome of Familial Mediterranean Fever (FMF) Patient: Pilot Study 
  12. Altered expression of miR-17 and miR-148b in pediatric familial mediterranean fever patients
  13. Evaluation of adropin, fibroblast growth factor-1 (FGF-1), and Toll-like receptor-1 (TLR1) biomarkers in patients with inflammatory bowel disease: gene expression of TNF-α as a marker of disease severity
  14. Emanuel syndrome due to unusual pattern
  15. Outlining the Clinical Profile of TCIRG1 14 Variants including 5 Novels with Overview of ARO Phenotype and Ethnic Impact in 20 Egyptian Families
  16. Sialic acid and anti-ganglioside M1 antibodies are invaluable biomarkers correlated with the severity of autism spectrum disorder
  17. Genetic and Epigenetic Regulation of MEFV Gene and Their Impact on Clinical Outcome in Auto-Inflammatory Familial Mediterranean Fever Patients
  18. Un estudio descriptivo de la enfermedad inflamatoria intestinal en un centro de atención terciario egipcio
  19. The role of the deficiency of vitamin B12 and folic acid on homocysteinemia in children with Turner syndrome
  20. Dynamic disequilibrium-based pathogenicity model in mutated pyrin’s B30.2 domain—Casp1/p20 complex
  21. BDNF as a potential predictive biomarker for patients with pediatric cerebral palsy
  22. Elevated expression of circulating CDR1as in childhood dilated cardiomyopathy patients; Expanding MAPK signaling pathway role in dilated cardiomyopathies pathogenesis.
  23. Multiplex ligation-dependent probe amplification versus fluorescent in situ hybridization for screening RB1 copy number variations in Egyptian patients with retinoblastoma
  24. Serum homocysteine, lipid profile and BMI as atherosclerotic risk factors in children with numerical chromosomal aberrations
  25. Circulating Irisin In Relation To Obesity and Anorexia Nervosa in Patients with Type 2 Diabetes
  26. Broadening the clinical spectrum of ALGS: an Egyptian cohort with five novel mutations in JAG1 gene
  27. Health-related quality of life in Egyptian patients with familial Mediterranean fever
  28. Oro‐dental features in Egyptian patients with familial mediterranean fever
  29. IGF1R, IGFALS, and IGFBP3 gene copy number variations in a group of non-syndromic Egyptian short children
  30. Differential Expression of micro RNAs and their Association with the Inflammatory Markers in Familial Mediterranean Fever Patients
  31. Genetic and Molecular Evaluation: Reporting Three Novel Mutations and Creating Awareness of Pycnodysostosis Disease
  32. Brain-Derived Neurotrophic Factor (BDNF) Levels In Relation To Depression In Egyptian Diabetic Women: A Pilot Study
  33. Serum Homocysteine, Lipid Profile and BMI as Atherosclerotic Risk Factors in Children with Numerical Chromosomal Aberrations
  34. Epigenetics and familial mediterranean fever
  35. The correlation of estrogen receptor 1 and progesterone receptor genes polymorphisms with recurrent pregnancy loss in a cohort of Egyptian women
  36. Chemerin as a Diagnostic Marker for Fmf in Egyptian Patients
  37. Assessment of Body Fat Distribution and Serum Liver-Type Fatty Acid-Binding Protein (L-FABP) and Neutrophil Gelatinase-Associated Lipocalin (NGAL): Potential Noninvasive Markers for Non-Alcoholic Fatty Liver Disease
  38. RANTES as a novel biomarker for atherogenic dyslipidemia and metabolic disturbances in patients with Type 2 Diabetes
  39. Clinical Implications of S100A12 and Resolvin D1 Serum Levels, and Related Genes in Children with Familial Mediterranean Fever
  40. Clinical, Biochemical, and Molecular Characterization of Metachromatic Leukodystrophy Among Egyptian Pediatric Patients: Expansion of the ARSA Mutational Spectrum
  41. Screening of the SHOX/PAR1 region using MLPA and miRNA expression profiling in a group of Egyptian children with non-syndromic short stature
  42. Inflammatory and endothelial dysfunction indices among Egyptian females with obesity classes I–III
  43. A descriptive study of NPHS1 and NPHS2 mutations in children with congenital nephrotic syndrome
  44. Assessment of Multiplex Ligation-Dependent Probe Amplification (MLPA) as a diagnostic test for Egyptian patients with Williams-Beuren syndrome
  45. Early-infantile onset epilepsy and developmental delay caused by bi-allelic GAD1 variants
  46. Carotid intima-media thickness, lipid profile, serum amyloid A and vitamin D status in children with familial Mediterranean fever
  47. Osteopontin, Malondialdehyde and Interleukin-1β Levels in Patients with Insulin Resistance and Dyslipidemia in Obese Egyptian Women
  48. Detection of low-grade mosaicism and its correlation with hormonal profile, testicular volume, and semen quality in a cohort of Egyptian Klinefelter and Klinefelter-like patients
  49. Microcephalic osteodysplastic primordial dwarfism type II: Additional nine patients with implications on phenotype and genotype correlation
  50. Clinical and cytogenomic characterization of de novo trisomy 9 mosaicism in an Egyptian family: phenotype/karyotype correlation
  51. Measurement of Serum Chemerin, Oxidized LDL, and Vitamin D Levels in Prader–Willi Syndrome: A Cross-Sectional Study in Pediatric Egyptian Patients
  52. DNA Damage and Neutrophil Elastase in Children with Prader-Willi Syndrome
  53. Oxidative Stress, Neutrophil Elastase and Vascular Endothelial Growth Factor in Obese Pregnant Women with Preeclampsia
  54. Mutation in the SLC29A3 Gene in an Egyptian Patient with H Syndrome: A Case Report and Review of Literature
  55. Genetic assessment of ten Egyptian patients with Sjögren–Larsson syndrome: expanding the clinical spectrum and reporting a novel ALDH3A2 mutation
  56. Early Detection and Management of Prader-Willi Syndrome in Egyptian Patients
  57. The association of +1150A polymorphism with low GH level in isolated growth hormone deficiency (IGHD) patients
  58. Apoptosis, reactive oxygen species and DNA damage in Familial Mediterranean Fever patients
  59. Cytogenomic characterization of 1q43q44 deletion associated with 4q32.1q35.2 duplication and phenotype correlation
  60. Assessment of physical growth, some oxidative stress biomarkers and vitamin D status in children with Familial Mediterranean Fever
  61. Screening of the most common MEFV mutations in a large cohort of Egyptian patients with Familial Mediterranean fever
  62. Evaluation of DNA damage profile in obese women and its association to risk of metabolic syndrome, polycystic ovary syndrome and recurrent preeclampsia
  63. Assessment of DNA damage in obese premenopausal women with metabolic syndrome
  64. Immunological Evaluation in Patients with Familial Mediterranean fever
  65. Association of vitamin D receptor gene polymorphism (VDR) with vitamin D deficiency, metabolic and inflammatory markers in Egyptian obese women
  66. Association of the Pro12Ala Polymorphism with the Metabolic Parameters in Women with Polycystic Ovary Syndrome
  67. Aicardi-Goutières syndrome: unusual neuro-radiological manifestations
  68. Registry of ocular anomalies among patients with genetic disorders attending the clinical genetics department at the National Research Center in Egypt
  69. Coenzyme Q10 and pro-inflammatory markers in children with Down syndrome: clinical and biochemical aspects
  70. Molybdenum cofactor and isolated sulphite oxidase deficiencies: Clinical and molecular spectrum among Egyptian patients
  71. Mercury toxicity and DNA damage in patients with Down syndrome
  72. Metabolic abnormalities in young Egyptian women with polycystic ovary syndrome and their relation to ADIPOQ gene variants and body fat phenotype
  73. Cross-sectional analysis of long bones in a sample of ancient Egyptians
  74. Behavioral problems, biochemical, and anthropometric characteristics of patients with Prader–Willi syndrome
  75. The role of H. pylori infection in gall bladder cancer: clinicopathological study
  76. Oxidative stress -a phenotypic hallmark of Fanconi anemia and Down syndrome: The effect of antioxidants
  77. Lipocalin-2 is an inflammatory biomarker associated with metabolic abnormalities in Egyptian obese children
  78. Indicators of the metabolic syndrome in obese adolescents
  79. Detection and Quantification of Free Radicals in Peroxisomal Disorders: A Comparative Study with Oxidative Stress Parameters
  80. Association of serum paraoxonase enzyme activity and oxidative stress markers with dyslipidemia in obese adolescents
  81. Mutation analysis of the GJB2 and GJB6 genes in Egyptian patients with autosomal recessive sensorineural nonsyndromic hearing loss
  82. Screening for common mutations in four FANCA gene exons in Egyptian Fanconi anemia patients
  83. Assessment of DNA Damage and Oxidative stress in Down syndrome
  84. Osteoporosis in Chronic Hepatitis C Virus with Advanced Liver Fibrosis
  85. The Significance of Articular Hand Manifestations in Chronic HCV Patients
  86. Anti-diuretic hormone and genetic study in primary nocturnal enuresis
  87. PP237-MON PREVALENCE OF RISK FACTORS FOR METABOLIC SYNDROME IN OBESE ADOLESCENTS
  88. Distinct Ocular Expression in Infants and Children With Down Syndrome in Cairo, Egypt
  89. Age–Related Differences in Body Composition in Egyptian Obese Females
  90. Assessment of metal content and oxidative stress in autistic Egyptian patients
  91. Screening seven common mitochondrial mutations in 28 Egyptian patients with suspected mitochondrial disease
  92. Clinical and molecular findings in eight Egyptian patients with suspected mitochondrial disorders and optic atrophy
  93. Growth curves of Egyptian patients with Turner syndrome
  94. Clinical significance of inflammatory and fibrogenic cytokines in diabetic nephropathy
  95. A cephalometric study of skulls from the Bahriyah oasis
  96. P53 protein and Ki-67 expression in chronic gastritis patients with positive Helicobacter pylori infection
  97. Sexual dysfunction in males with hepatitis C virus: Relevance to histopathologic changes and peginterferon treatment
  98. Variable Associations of Klinefelter Syndrome in Children
  99. Predictive Value Of Biochemical Markers In Pregnancy Induced Hypertension
  100. Management of rare side effects of peginterferon and ribavirin therapy during hepatitis C treatment: a case report
  101. Polyploidy in chronic lymphocytic leukemia with p53 deletion detected by fish: a case report
  102. The Effect of Diet on Antioxidant Status in Patients with Galactosemia